281 related articles for article (PubMed ID: 16143689)
21. Use of total lymphocyte count to predict absolute CD4 count in HIV-seropositive cases.
Gautam H; Saini S; Bhalla P; Singh T
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):292-5. PubMed ID: 20923954
[TBL] [Abstract][Full Text] [Related]
22. Should absolute lymphocyte count be used as a surrogate marker for CD4+ count in patients with HIV/AIDS?
Jibrin YB; Yusuph H; Garbati MA; Gashau W; Abja UM
Afr J Med Med Sci; 2006 Mar; 35(1):9-13. PubMed ID: 17209321
[TBL] [Abstract][Full Text] [Related]
23. Estimation of CD4 T-lymphocyte counts from percent CD4 T-lymphocyte determinations in HIV-1-infected subjects in sub-Saharan Africa.
Sandström E; Urassa W; Bakari M; Swai A; Mhalu F; Biberfeld G; Pallangyo K
Int J STD AIDS; 2003 Aug; 14(8):547-51. PubMed ID: 12935385
[TBL] [Abstract][Full Text] [Related]
24. [The prognostic value of virology and immunology markers in Chinese HIV-1 infected people].
Lin X; Xu L; Shao Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):41-4. PubMed ID: 12759951
[TBL] [Abstract][Full Text] [Related]
25. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
Seminari E; De Silvestri A; Boschi A; Tinelli C
AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
[TBL] [Abstract][Full Text] [Related]
26. Pneumocystis jirovecii prophylaxis discontinuation based upon total lymphocyte count in HIV-infected adults treated with antiretroviral therapy.
Cheung C; Shuter J
Int J STD AIDS; 2010 Jun; 21(6):406-9. PubMed ID: 20606220
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.
Podlekareva D; Mocroft A; Dragsted UB; Ledergerber B; Beniowski M; Lazzarin A; Weber J; Clumeck N; Vetter N; Phillips A; Lundgren JD;
J Infect Dis; 2006 Sep; 194(5):633-41. PubMed ID: 16897662
[TBL] [Abstract][Full Text] [Related]
28. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
Gandhi T; Wei W; Amin K; Kazanjian P
Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
[TBL] [Abstract][Full Text] [Related]
29. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.
Miziara ID; Weber R
Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726
[TBL] [Abstract][Full Text] [Related]
30. The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients.
Olawumi HO; Olatunji PO
HIV Med; 2006 Sep; 7(6):351-5. PubMed ID: 16903978
[TBL] [Abstract][Full Text] [Related]
31. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
32. [The characteristics of opportunistic infections in 181 HIV/AIDS patients in China].
Wang XC; Huang XJ; Zhang T; Liang LC; Jiao YM; Zhang HW; Wu H
Zhonghua Nei Ke Za Zhi; 2007 May; 46(5):379-82. PubMed ID: 17637305
[TBL] [Abstract][Full Text] [Related]
33. Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men.
Lau B; Gange SJ; Phair JP; Riddler SA; Detels R; Margolick JB
AIDS; 2003 Sep; 17(14):2035-44. PubMed ID: 14502006
[TBL] [Abstract][Full Text] [Related]
34. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
35. Quality control of the total lymphocyte count parameter obtained from routine haematology analyzers, and its relevance in HIV management.
Marshall S; Sippy N; Broome H; Abayomi A
Afr J Med Med Sci; 2006 Jun; 35(2):161-3. PubMed ID: 17209312
[TBL] [Abstract][Full Text] [Related]
36. Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
Bongiovanni M; Gori A; Lepri AC; Antinori A; de Luca A; Pagano G; Chiodera A; Puoti M; Monforte Ad;
Clin Infect Dis; 2007 Sep; 45(5):650-3. PubMed ID: 17683003
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a manual CD4+ count kit for determination of absolute CD4+ T-lymphocyte counts.
Mitchai M; Susaengrat W; Krissadarak K; Mitchai J; Leeratanapetch N
J Med Assoc Thai; 2008 Oct; 91(10):1495-8. PubMed ID: 18972890
[TBL] [Abstract][Full Text] [Related]
38. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.
Madec Y; Laureillard D; Pinoges L; Fernandez M; Prak N; Ngeth C; Moeung S; Song S; Balkan S; Ferradini L; Quillet C; Fontanet A
AIDS; 2007 Jan; 21(3):351-9. PubMed ID: 17255742
[TBL] [Abstract][Full Text] [Related]
39. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
[TBL] [Abstract][Full Text] [Related]
40. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
Wolbers M; Bucher HC; Furrer H; Rickenbach M; Cavassini M; Weber R; Schmid P; Bernasconi E; Hirschel B; Battegay M;
HIV Med; 2008 Jul; 9(6):397-405. PubMed ID: 18410354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
